Literature DB >> 3147372

Introduction of genes for leucine biosynthesis from Clostridium pasteurianum into C. acetobutylicum by cointegrate conjugal transfer.

J D Oultram1, H Peck, J K Brehm, D E Thompson, T J Swinfield, N P Minton.   

Abstract

A Clostridium pasteurianum gene bank was constructed in Escherichia coli, using plasmid pAT153, and several chromosomal fragments found which complemented both leuB and leuC mutations in auxotrophic E. coli K12 strains. No fragments capable of complementing leuA or leuD mutations were identified. Conjugal transfer of the leuB/leuC genes from Bacillus subtilis into two different Leu- C. acetobutylicum auxotrophic strains was elicited by their incorporation into a large plasmid cointegrate composed of the conjugal plasmid pAM beta 1 and a specially constructed gram-positive, replication-deficient plasmid, pMTL21 EC. Inheritance of the cointegrate plasmid restored one of the auxotrophic C. acetobutylicum strains to prototrophy. The second strain remained Leu-.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3147372     DOI: 10.1007/bf00340200

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  11 in total

1.  Characterization and transferability of Clostridium perfringens plasmids.

Authors:  G Brefort; M Magot; H Ionesco; M Sebald
Journal:  Plasmid       Date:  1977-11       Impact factor: 3.466

2.  Sequence of the adenine methylase gene of the Streptococcus faecalis plasmid pAM beta 1.

Authors:  J Brehm; G Salmond; N Minton
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

3.  Cloning and complete nucleotide sequence of the Bacillus stearothermophilus tryptophanyl tRNA synthetase gene.

Authors:  D A Barstow; A F Sharman; T Atkinson; N P Minton
Journal:  Gene       Date:  1986       Impact factor: 3.688

4.  Cloning of leucine genes of alkalophilic Bacillus No. 221 in E. coli and B. subtilis.

Authors:  H Honda; C Kato; T Kudo; K Horikoshi
Journal:  J Biochem       Date:  1984-05       Impact factor: 3.387

5.  The pMTL nic- cloning vectors. I. Improved pUC polylinker regions to facilitate the use of sonicated DNA for nucleotide sequencing.

Authors:  S P Chambers; S E Prior; D A Barstow; N P Minton
Journal:  Gene       Date:  1988-08-15       Impact factor: 3.688

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Genetic studies of leucine biosynthesis in Bacillus subtilis.

Authors:  J B Ward; S A Zahler
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

8.  Cloning in Escherichia coli of genes involved in the synthesis of proline and leucine in Desulfovibrio desulfuricans Norway.

Authors:  M Fons; B Cami; J C Patte; M Chippaux
Journal:  Mol Gen Genet       Date:  1987-01

9.  Characterization of chimeric plasmid cloning vehicles in Bacillus subtilis.

Authors:  T Gryczan; A G Shivakumar; D Dubnau
Journal:  J Bacteriol       Date:  1980-01       Impact factor: 3.490

10.  Molecular cloning of the Pseudomonas carboxypeptidase G2 gene and its expression in Escherichia coli and Pseudomonas putida.

Authors:  N P Minton; T Atkinson; R F Sherwood
Journal:  J Bacteriol       Date:  1983-12       Impact factor: 3.490

View more
  10 in total

1.  Can engineered bacteria help control cancer?

Authors:  R K Jain; N S Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Identification of the structural genes for N-acetylmuramoyl-L-alanine amidase and its modifier in Bacillus subtilis 168: inactivation of these genes by insertional mutagenesis has no effect on growth or cell separation.

Authors:  P Margot; D Karamata
Journal:  Mol Gen Genet       Date:  1992-04

3.  Bacillus subtilis alpha-phosphoglucomutase is required for normal cell morphology and biofilm formation.

Authors:  Vladimir Lazarevic; Blazenka Soldo; Noël Médico; Harold Pooley; Sierd Bron; Dimitri Karamata
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

4.  The gram-positive cloning vector pBD64 arose by a 1844 bp deletion of pC194 derived DNA.

Authors:  N P Minton; T J Swinfield; J K Brehm; J D Oultram
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

5.  Functional characterization of an extended binding component of the actin-ADP-ribosylating C2 toxin detected in Clostridium botulinum strain (C) 2300.

Authors:  Charlott Sterthoff; Alexander E Lang; Carsten Schwan; Andreas Tauch; Klaus Aktories
Journal:  Infect Immun       Date:  2010-02-09       Impact factor: 3.441

6.  SpoIIE is necessary for asymmetric division, sporulation, and expression of sigmaF, sigmaE, and sigmaG but does not control solvent production in Clostridium acetobutylicum ATCC 824.

Authors:  Changhao Bi; Shawn W Jones; Daniel R Hess; Bryan P Tracy; Eleftherios T Papoutsakis
Journal:  J Bacteriol       Date:  2011-07-22       Impact factor: 3.490

7.  Electrotransformation of Clostridium thermocellum.

Authors:  Michael V Tyurin; Sunil G Desai; Lee R Lynd
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

8.  Electro-transformation of Clostridium beijerinckii NRRL B-592 with shuttle plasmid pHR106 and recombinant derivatives.

Authors:  G A Birrer; W R Chesbro; R M Zsigray
Journal:  Appl Microbiol Biotechnol       Date:  1994-03       Impact factor: 4.813

9.  Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator.

Authors:  Glen P Carter; Dena Lyras; David L Allen; Kate E Mackin; Pauline M Howarth; Jennifer R O'Connor; Julian I Rood
Journal:  J Bacteriol       Date:  2007-08-10       Impact factor: 3.490

10.  Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo.

Authors:  J Theys; O Pennington; L Dubois; G Anlezark; T Vaughan; A Mengesha; W Landuyt; J Anné; P J Burke; P Dûrre; B G Wouters; N P Minton; P Lambin
Journal:  Br J Cancer       Date:  2006-10-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.